These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30986113)

  • 21. Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: Qualitative study.
    Lawton J; Rankin D; Hartnell S; Lee T; Dover AR; Reynolds RM; Hovorka R; Murphy HR; Hart RI;
    Diabet Med; 2023 May; 40(5):e15072. PubMed ID: 36807582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development?
    Trevitt S; Simpson S; Wood A
    J Diabetes Sci Technol; 2016 May; 10(3):714-23. PubMed ID: 26589628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.
    Musolino G; Dovc K; Boughton CK; Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Ashcroft N; Wilinska ME; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Pediatr Diabetes; 2019 Sep; 20(6):794-799. PubMed ID: 31140654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users.
    Tanenbaum ML; Iturralde E; Hanes SJ; Suttiratana SC; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
    J Health Psychol; 2020 Mar; 25(4):429-438. PubMed ID: 28810490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceived Usefulness of Continuous Glucose Monitoring Devices at the Workplace: Secondary Analysis of Data From a Qualitative Study.
    Scharf J; Nguyen XQ; Vu-Eickmann P; Krichbaum M; Loerbroks A
    J Diabetes Sci Technol; 2019 Mar; 13(2):242-247. PubMed ID: 30027749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Making sense of blood glucose data and self-management in individuals with type 2 diabetes mellitus: A qualitative study.
    Despins LA; Wakefield BJ
    J Clin Nurs; 2020 Jul; 29(13-14):2572-2588. PubMed ID: 32279366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accessing health services through the back door: a qualitative interview study investigating reasons why people participate in health research in Canada.
    Townsend A; Cox SM
    BMC Med Ethics; 2013 Oct; 14():40. PubMed ID: 24119203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescents' and their parents' experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study.
    Rankin D; Kimbell B; Hovorka R; Lawton J
    Chronic Illn; 2022 Dec; 18(4):742-756. PubMed ID: 33472409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.
    Adams RN; Tanenbaum ML; Hanes SJ; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
    Diabetes Technol Ther; 2018 Oct; 20(10):648-653. PubMed ID: 30239219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.
    Ruan Y; Thabit H; Leelarathna L; Hartnell S; Wilinska ME; Tauschmann M; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Evans ML; Pieber TR; Arnolds S; Hovorka R;
    Diabetes Obes Metab; 2017 Oct; 19(10):1485-1489. PubMed ID: 28371223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes.
    Ruan Y; Bally L; Thabit H; Leelarathna L; Hartnell S; Tauschmann M; Wilinska ME; Evans ML; Mader JK; Kojzar H; Dellweg S; Benesch C; Arnolds S; Pieber TR; Hovorka R
    Diabetes Obes Metab; 2018 Aug; 20(8):2004-2008. PubMed ID: 29577536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
    Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
    Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appearance of Do-It-Yourself closed-loop systems to manage type 1 diabetes.
    Hng TM; Burren D
    Intern Med J; 2018 Nov; 48(11):1400-1404. PubMed ID: 30387315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural implications of traditional treatment and closed-loop automated insulin delivery systems in Type 1 diabetes: applying a cognitive restraint theory framework.
    Kahkoska AR; Mayer-Davis EJ; Hood KK; Maahs DM; Burger KS
    Diabet Med; 2017 Nov; 34(11):1500-1507. PubMed ID: 28626906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.
    Dassau E; Brown SA; Basu A; Pinsker JE; Kudva YC; Gondhalekar R; Patek S; Lv D; Schiavon M; Lee JB; Dalla Man C; Hinshaw L; Castorino K; Mallad A; Dadlani V; McCrady-Spitzer SK; McElwee-Malloy M; Wakeman CA; Bevier WC; Bradley PK; Kovatchev B; Cobelli C; Zisser HC; Doyle FJ
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3878-86. PubMed ID: 26204135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-Up Support for Effective type 1 Diabetes self-management (The FUSED Model): A systematic review and meta-ethnography of the barriers, facilitators and recommendations for sustaining self-management skills after attending a structured education programme.
    Campbell F; Lawton J; Rankin D; Clowes M; Coates E; Heller S; de Zoysa N; Elliott J; Breckenridge JP
    BMC Health Serv Res; 2018 Nov; 18(1):898. PubMed ID: 30482202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis.
    Pease A; Lo C; Earnest A; Kiriakova V; Liew D; Zoungas S
    Diabetes Care; 2020 Aug; 43(8):1967-1975. PubMed ID: 32669412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives.
    Pickup JC; Ford Holloway M; Samsi K
    Diabetes Care; 2015 Apr; 38(4):544-50. PubMed ID: 25552422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.